Lifecore Biomedical Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Lifecore Biomedical Inc.
- Former names
- Landec Corp \CA\
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Chaska
- Headquarters state / province
- Minnesota
- Headquarters country
- United States
- Fiscal year end
- May
- Ticker symbol
- LFCR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001005286
- EIN
- 94-3025618
Board of directors
-
Christopher S. Kiper · DirectorSince 2023
-
Craig A. Barbarosh · DirectorSince 2023
-
Humberto Calheiros Antunes · DirectorSince 2024
-
James G. Hall · Director · Chief Executive OfficerSince 2023
-
Jason Aryeh · DirectorSince 2024
-
Jeffrey L. Edwards · DirectorSince 2023
-
Joshua Schechter · DirectorSince 2023
-
Lovas Katrina Houde · DirectorSince 2023
-
Matthew E. Korenberg · DirectorSince 2024
-
Nathaniel Calloway · DirectorSince 2023
-
Nelson Obus · DirectorSince 2023
-
Paul Harold Johnson · DirectorSince 2024
-
Paul Josephs · Director · Chief Executive OfficerSince 2024
-
Raymond H. Diradoorian · DirectorSince 2023
-
Raymond T. White · DirectorSince 2023
Chief executives
Paul Josephs
· Chief Executive Officer
Dates unknown
James G. Hall
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
-
100.0%
-
100.0%
-
100.0%
-
100.0%
-
100.0%
-
100.0%
-
100.0%
Board connections
6 of this board's directors also sit on 10 other boards.
- via Christopher S. Kiper and Raymond T. White
- via Christopher S. Kiper and Raymond T. White
- via Joshua Schechter
- via Jeffrey L. Edwards
- via Craig A. Barbarosh
- via Jeffrey L. Edwards
- via Jason Aryeh
- via Jason Aryeh
- via Joshua Schechter
- via Craig A. Barbarosh
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Legion Partners, L.P. I Director, 10% owner | Grant or award | +25,907 | — | — |
| Jun 4, 2026 | Nelson Obus Director | Grant or award | +25,907 | — | — |
| Jun 4, 2026 | Jason Aryeh Director | Grant or award | +25,907 | — | — |
| Jun 4, 2026 | Joshua Schechter Director | Grant or award | +25,907 | — | — |
| Jun 4, 2026 | Matthew E. Korenberg Director | Grant or award | +25,907 | — | — |
| Jun 4, 2026 | Humberto Calheiros Antunes Director | Grant or award | +25,907 | — | — |
| Jun 4, 2026 | Paul Harold Johnson Director | Grant or award | +25,907 | — | — |
| Jun 4, 2026 | Lovas Katrina Houde Director | Grant or award | +25,907 | — | — |
| May 20, 2026 | Paul Josephs Director, Officer (Chief Executive Officer) | Shares withheld for tax | −40,413 | $4.57 | $184,687 |
| Apr 14, 2026 | Salus Thomas D. Officer (Chief Legal & Administration) | Shares withheld for tax | −24,645 | $5.20 | $128,154 |
| Mar 2, 2026 | Salus Thomas D. Officer (Chief Legal & Administration) | Grant or award | +30,000 | — | — |
| Sep 3, 2025 | Lake Ryan David Officer (Chief Financial Officer) | Shares withheld for tax | −22,932 | $7.71 | $176,806 |
| Jul 15, 2025 | Nelson Obus Director | Grant or award | +19,506 | — | — |
| Jul 15, 2025 | Legion Partners Holdings, LLC Director, 10% owner | Grant or award | +19,506 | — | — |
| Jul 15, 2025 | Paul Harold Johnson Director | Grant or award | +19,506 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.